M&G PLC Procept Bio Robotics Corp Transaction History
M&G PLC
- $16.6 Billion
- Q2 2025
A detailed history of M&G PLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, M&G PLC holds 143,559 shares of PRCT stock, worth $4.99 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
143,559
Previous 143,546
0.01%
Holding current value
$4.99 Million
Previous $8.36 Million
1.12%
% of portfolio
0.05%
Previous 0.06%
Shares
3 transactions
Others Institutions Holding PRCT
# of Institutions
292Shares Held
44MCall Options Held
236KPut Options Held
91.9K-
Vanguard Group Inc Valley Forge, PA5.25MShares$182 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$121 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY2.16MShares$75 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.53MShares$53.1 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.32MShares$46 Million0.01% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $1.55B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...